Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.97 USD | +2.77% | -4.50% | +67.80% |
May. 14 | Taysha Gene Therapies Q1 Net Loss Narrows, Revenue Declines -- Shares Down After Hours | MT |
May. 14 | Transcript : Taysha Gene Therapies, Inc., Q1 2024 Earnings Call, May 14, 2024 |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
TAYSHA GENE THERAPIES, INC. | Other Biotechnology & Medical Research | +2.77% | -4.50% | +67.80% | +280.04% | - | 555M |
Technical Rankings Surperformance
- Stock Market
- Equities
- TSHA Stock
- Charts Taysha Gene Therapies, Inc.
- Comparison Chart